JUPITER NEUROSCIENCES, INC. Increase (Decrease) in Prepaid Expense and Other Assets
JUPITER NEUROSCIENCES, INC. (JUNS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $27.81 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2025-11-14
- JUPITER NEUROSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$32.32K.
- JUPITER NEUROSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was $36.03K.
- JUPITER NEUROSCIENCES, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-03-31 was $24.11K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month |
|---|---|---|---|
| 2025-09-30 | -$32.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $3.70K derived: sum of 2 quarters · filed 2025-11-14 | $27.81K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $36.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | $60.13K 10-Q · filed 2025-08-19 | |
| 2025-03-31 | $24.11K 10-Q · filed 2025-05-15 | ||
| 2024-09-30 | -$25.00K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |